Webinar

Heart Failure is progressive disease state previously manageable only by guideline directed medical therapy (GDMT). This webinar will give an overview of CCM® therapy, the indications for use, and the clinical studies leading to the breakthrough device approval from the FDA. Case studies will be shown to emphasize the need for patient screening, as well as give the audience real world examples of how to implement CCM® therapy in your practice and access to your patients.